REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jasz-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: JASZ-PHARMA Kereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Jasz-Pharma Bt. is a company based in Hungary, with its head office in Jaszkiser. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was incorporated on December 04, 2000. 6 (2023) employees currently work for Jasz-Pharma Bt.. From the latest financial highlights, Jasz-Pharma Bt. reported a net sales revenue increase of 7.36% in 2022. During that time, Jasz-Pharma Bt.’s total assets grew by 229.69%. In 2022, Jasz-Pharma Bt.’s net profit margin increased by 2.1%.

Headquarters
Fo u. 8.
Jaszkiser; Jasz-Nagykun-Szolnok; Postal Code: 5137

Contact Details: Purchase the Jasz-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Jasz-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Jasz-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Jasz-Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Jasz-Pharma Bt. report to view the information.
Incorporation Date:
December 04, 2000
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Business Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Jasz-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.36%▲
Total operating revenue
8.54%▲
Operating profit (EBIT)
170.12%▲
EBITDA
159.59%▲
Net Profit (Loss) for the Period
179.19%▲
Total assets
229.69%▲
Total equity
57.34%▲
Operating Profit Margin (ROS)
2.27%▲
Net Profit Margin
2.1%▲
Return on Equity (ROE)
15.9%▲
Quick Ratio
-0.16%▼
Cash Ratio
-0.32%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo